Clinical Trial Update: Clinical Study of Venetoclax Combined with CACAG Regimen in the Treatment of Newly Diagnosed Acute Myeloid Leukemia [Phase 2]

View source ↗

Summary

This Phase 2 trial studied venetoclax in combination with the CACAG regimen for newly diagnosed acute myeloid leukemia. The study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• CACAG regimen
• Venetoclax (venetoclax)

Snippet

Sponsor: Chinese PLA General Hospital | Conditions: Acute Myeloid Leukemia | Phase 2 | Status: COMPLETED